Publication | Open Access

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

VaccinationVaccine SafetyPhase 1/2Vaccine DevelopmentPreliminary ReportImmunologyVaccine EfficacyMedicineChadox1 Ncov-19 VaccineCovid-19